iifl-logo-icon 1

Vista Pharmaceuticals Ltd Share Price

15.48
(0.06%)
Jul 16, 2024|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open15.1
  • Day's High15.89
  • 52 Wk High19.7
  • Prev. Close15.47
  • Day's Low14.7
  • 52 Wk Low8.12
  • Turnover (lac)2.3
  • P/E0
  • Face Value2
  • Book Value9.99
  • EPS0
  • Mkt. Cap (Cr.)60.09
  • Div. Yield0
No Records Found

Vista Pharmaceuticals Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

15.1

Prev. Close

15.47

Turnover(Lac.)

2.3

Day's High

15.89

Day's Low

14.7

52 Week's High

19.7

52 Week's Low

8.12

Book Value

9.99

Face Value

2

Mkt Cap (₹ Cr.)

60.09

P/E

0

EPS

0

Divi. Yield

0

Vista Pharmaceuticals Ltd Corporate Action

11 Sep 2023

12:00 AM

AGM

Announcement Date: 11 Sep, 2023

arrow

14 Jun 2024

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

10 Feb 2024

12:00 AM

EGM

arrow

Vista Pharmaceuticals Ltd NEWS AND UPDATE

No data found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Vista Pharmaceuticals Ltd SHAREHOLDING SNAPSHOT

17 Jul, 2024|12:46 AM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 12.17%

Foreign: 12.17%

Indian: 15.62%

Non-Promoter- 0.04%

Institutions: 0.03%

Non-Institutions: 72.16%

Custodian: 0.00%

Share Price

Vista Pharmaceuticals Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Loading...
Y/e 31 Mar( In .Cr)Mar-2023Mar-2022Mar-2021Mar-2020

Equity Capital

13.67

7.36

7.36

6.07

Preference Capital

0

0

0

0

Reserves

23.04

28.09

25.49

23.57

Net Worth

36.71

35.45

32.85

29.64

Minority Interest

View Balance Sheet
Loading...
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2019Mar-2018

Revenue

1.26

22.75

31.07

28.91

yoy growth (%)

-94.43

-26.75

7.45

19.58

Raw materials

-0.73

-23.93

-25.41

-15.96

As % of sales

57.65

105.17

81.78

55.2

Employee costs

-1.15

-1.48

-1.36

-1.05

View Profit & Loss
Loading...
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2019Mar-2018

Profit before tax

-3.68

-3.93

1.14

2.82

Depreciation

-0.72

-1.34

-1.36

-1.33

Tax paid

1.8

0.25

-0.2

-0.64

Working capital

-7.21

-2.48

-0.12

5.94

Other operating items

View Cash Flow
Loading...
Y/e 31 MarMar-2021Mar-2020Mar-2019Mar-2018

Growth matrix (%)

Revenue growth

-94.43

-26.75

7.45

19.58

Op profit growth

-63.94

-488

-76.84

74.74

EBIT growth

-10.72

-184.93

-35.91

109.75

Net profit growth

-48.73

-491.44

-57.03

75.27

View Ratios

No Record found

Vista Pharmaceuticals Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceuticals Industries Ltd

SUNPHARMA

1,579.25

124.153,78,914.98867.60.855,536.9998.75

Cipla Ltd

CIPLA

1,511.35

32.861,22,044.231,038.40.563,444.92346.41

Divis Laboratories Ltd

DIVISLAB

4,564.95

76.931,21,185.085310.662,259507.93

Zydus Lifesciences Ltd

ZYDUSLIFE

1,184.85

34.691,19,223.631,405.20.253,172.6156.19

Dr Reddys Laboratories Ltd

DRREDDY

6,643.15

25.871,10,827.471,034.80.65,081.81,458.96

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Vista Pharmaceuticals Ltd

Management

Register Office

Registrar Office

Chairman & Wholetime Director

Dhananjaya Alli

Non-Exec. & Independent Dir.

G Narendra

Non-Exec & Non-Independent Dir

M H Rao

Non-Exec & Non-Independent Dir

Stanley Prabhakar Reddy

Non-Exec. & Independent Dir.

Umesh V Banakar

Non-Exec. & Independent Dir.

Chakravarthula Divya Bhavani

Director

Umakanth Katta

Director

Divakar Reddy Yerrabommanahalli

Managing Director

Murali Meraga

Whole Time Director (Operatio

Pavan Sathvik Gilaka

Company Sec. & Compli. Officer

Barkha Jain

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

Vista Pharmaceuticals Limited was incorporated on January 25,1991 with the Registrar of Companies, Andhra Pradesh & has obtained Certificate of Commencement of Business on February 7, 1991. The Company is engaged in the formulation of pharmaceutical products. It offers a range of products mainly into the therapeutic areas of gastrointestinal, pain management and anti-infection, catering to common ailments. This division is a primary contributor to the domestic sales of Torrent Pharmaceuticals Ltd., based in Hyderabad, India.The Company was in process of setting up a 100% EOU for manufacture of drug formulations with an installed capacity of 400 million tablets & 200 million capsules per annum. Apart from these, the Company offers over the counter & prescription generic drug products consisting of tablets, capsules and liquids covering various therapeutic categories. The Company was founded in 1992 to Formulate, Register, Produce, Market and Distribute High Quality Pharmaceutical Products, initially focusing on the United States Market of expanding Globally. It is the first Indian Company to obtain USFDA Approvals to produce OTC as well as Prescription Drugs to US Market in 1994. It is the first Indian Company to export OTC as well as Prescription Drugs to US in 1996. The Companys Indian Facility got USFDA Approval in June 2010 to produce ANDA products to US Market. It established an extensive Marketing and Distribution Network in the United States. The Company operations ar
Read More

Company FAQs

What is the Vista Pharmaceuticals Ltd share price today?

Down Arrow

The Vista Pharmaceuticals Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is Rs.₹15.48 today.

What is the Market Cap of Vista Pharmaceuticals Ltd?

Down Arrow

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Vista Pharmaceuticals Ltd is ₹60.09 Cr. as of 16 Jul ‘24

What is the PE and PB ratio of Vista Pharmaceuticals Ltd?

Down Arrow

The PE and PB ratios of Vista Pharmaceuticals Ltd is 0 and 1.55 as of 16 Jul ‘24

What is the 52 Week High and Low of Vista Pharmaceuticals Ltd?

Down Arrow

The 52-week high/low is the highest and lowest price at which a Vista Pharmaceuticals Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Vista Pharmaceuticals Ltd is ₹8.12 and ₹19.7 as of 16 Jul ‘24

What is the CAGR of Vista Pharmaceuticals Ltd?

Down Arrow

Vista Pharmaceuticals Ltd's CAGR for 5 Years at 3.68%, 3 Years at 11.96%, 1 Year at 54.80%, 6 Month at -8.35%, 3 Month at 14.67% and 1 Month at 14.58%.

What is the shareholding pattern of Vista Pharmaceuticals Ltd?

Down Arrow

The shareholding pattern of Vista Pharmaceuticals Ltd is as follows:
Promoters - 27.81 %
Institutions - 0.03 %
Public - 72.16 %

Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.